Barriers to entry, brand advertising, and generic entry in the US pharmaceutical industry

This publication has 13 references indexed in Scilit:

• The importance of the physician in the generic versus trade-name prescription decision.
  The RAND Journal of Economics, 1998
• On the application of robust, regression- based diagnostics to models of conditional means and conditional variances
  Journal of Econometrics, 1991
• Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry
  Brookings Papers on Economic Activity. Microeconomics, 1991
• Persuasion or Information? Promotion and the Shares of Brand Name and Generic Pharmaceuticals
  The Journal of Law and Economics, 1988
• Do Entry Conditions Vary across Markets?
  Brookings Papers on Economic Activity, 1987
• Advertising and Entry Deterrence: An Exploratory Model
  Journal of Political Economy, 1983
• Persuasion or Information? The Economics of Prescription Drug Advertising
  The Journal of Law and Economics, 1981
• Notes on Advertising, Economies of Scale, and Entry Barriers
  The Quarterly Journal of Economics, 1980
• Entry, Capacity, Investment and Oligopolistic Pricing
  The Bell Journal of Economics, 1977
• The Theory of Supply with Applications to the Ethical Pharmaceutical Industry
  The Journal of Law and Economics, 1975